New group of potential diabetes drugs with fewer side effects can reprogram insulin-resistant cells to be healthier

Using a blend of computer modeling, structural and cell-based studies, scientists at The Wertheim UF Scripps Institute have ...
The American Journal of Managed Care

Evolving Management and Pathogenesis of IgA Nephropathy

Explore the evolution of IgA nephropathy treatment, highlighting new guidelines and targeted therapies that improve patient outcomes.
The American Journal of Managed Care

ASH 2025 Highlights Reinforce Durability, Safety, and Strategic Sequencing in MCL Therapy

Michael Wang, MD, highlights several notable abstracts from ASH 2025 that collectively underscore continued progress in ...
Frontiers

Targeting Inflammation: The Emerging Role of JAK Inhibitors in Inflammatory Disease Pharmacotherapy

Janus Kinase inhibitors (JAKis) are approved for the management of several chronic inflammatory diseases, from rheumatic conditions, to dermatological and ...
Frontiers

Pharmacogenetics in Optimising Therapy of Infectious Diseases: Understanding Host Genetic Variants Influencing Drug Metabolism, Immune Response, and Adverse Drug Reactions

Pharmacogenetics and pharmacogenomics are increasingly recognised as playing a pivotal role in the advancement of personalised medicine, especially in the ...